LONG-TERM ORAL CIPROFLOXACIN IN THE TREATMENT OF PROSTHETIC VALVE ENDOCARDITIS DUE TO PSEUDOMONAS-AERUGINOSA

UZUN O., AKALIN H., UNAL S., DEMIRCIN M., YORGANCIOGLU A., UGURLU B.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, vol.24, no.6, pp.797-800, 1992 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 6
  • Publication Date: 1992
  • Doi Number: 10.3109/00365549209062467
  • Journal Name: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, Public Affairs Index
  • Page Numbers: pp.797-800
  • Hacettepe University Affiliated: Yes

Abstract

Prosthetic valve endocarditis caused by Pseudomonas aeruginosa is refractory to medical treatment alone and early valve replacement is necessary. We describe a 40-year-old patient in whom endocarditis developed in the early postoperative period, and reoperation was not considered feasible. Ciprofloxacin was administered orally in order to suppress bacteremia for 36 months. Long-term oral ciprofloxacin may provide an opportunity in the treatment of prosthetic valve endocarditis caused by Ps. aeruginosa in patients who are unfavorable candidates for reoperation.